Skip to main content

Lucira Health, Inc. (LHDX)

NASDAQ: LHDX · IEX Real-Time Price · USD
5.91
+0.02 (0.34%)
After-hours:Oct 22, 2021 5:25 PM EDT
5.89
0.02 (0.34%)
At close: Oct 22, 4:00 PM
Market Cap229.10M
Revenue (ttm)17.22M
Net Income (ttm)n/a
Shares Out38.48M
EPS (ttm)-3.52
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume124,221
Open5.90
Previous Close5.87
Day's Range5.76 - 5.96
52-Week Range4.23 - 37.99
Betan/a
AnalystsHold
Price Target7.25 (+23.1%)
Est. Earnings DateNov 11, 2021

About LHDX

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and ...

IndustryMedical Devices
IPO DateFeb 5, 2021
Employees84
Stock ExchangeNASDAQ
Ticker SymbolLHDX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for Lucira Health stock is "Hold." The 12-month stock price forecast is 7.25, which is an increase of 23.09% from the latest price.

Price Target
$7.25
(23.09% upside)
Analyst Consensus: Hold

News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lucira Health, Inc. - LHDX

NEW YORK, Oct. 15, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Lucira Health, Inc. ("Lucira" or the "Company") (NASDAQ: LHDX). Such investors are advised to con...

1 week ago - PRNewsWire

LUCIRA™ HEALTH COVID-19 Test Approved for Sale in Singapore

Singapore Health Sciences Authority issues approval by its Pandemic Special Access Route (PSAR) for the LUCIRA CHECK IT COVID-19 Test Kit. Lucira has partnered with Labgistics Asia Pte Ltd for the impor...

1 week ago - GlobeNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lucira Health, Inc. - LHDX

New York, New York--(Newsfile Corp. - October 8, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Lucira Health, Inc. ("Lucira" or the "Company") (NASDAQ: LHDX). Such investors ar...

2 weeks ago - Newsfile Corp

LUCIRA™ HEALTH Provides Statement on Copan's Recall of its FLOQSwabs

EMERYVILLE, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of t...

2 weeks ago - GlobeNewsWire

LUCIRA™ HEALTH Hires Tony Allen as Chief Operations Officer

Veteran operations expert joins Lucira's management team Veteran operations expert joins Lucira's management team

1 month ago - GlobeNewsWire

LUCIRA™ HEALTH Hires Ghazi Kashmolah as Chief Quality Officer and EVP Regulatory Affairs

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and...

2 months ago - Business Wire

3 Beaten-Down Biotech Stocks to Buy Right Now

These biotech stocks might be down, but they're not out.

Other symbols:BLUEVRTX
2 months ago - The Motley Fool

Lucira Health Stock Soars After Q2 Sales Jump 175% Sequentially

Lucira Health Inc (NASDAQ: LHDX) reported sales of $12.4 million in Q2, the firm's second full quarter of commercial activity, beating the consensus estimate of $8 million. Sales increased 175% sequenti...

2 months ago - Benzinga

Lucira Health Announces Second Quarter 2021 Financial Results

EMERYVILLE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commerc...

2 months ago - GlobeNewsWire

2 Under-the-Radar Stocks to Buy Now

The stocks have huge upside potential that investors are overlooking.

Other symbols:BBBY
3 months ago - The Motley Fool

5 Stocks to Own for the Surge in Coronavirus Variants

Despite easing restrictions, COVID is going to be around a lot longer than many think.

Other symbols:ABTBNTXFLGT
3 months ago - The Motley Fool

Why Lucira Health Is Rocketing Higher Today

The company may be the beneficiary of another social media-inspired buying frenzy.

3 months ago - The Motley Fool

LUCIRA™ HEALTH Hires Chief Revenue Officer Kevin Collins

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

4 months ago - Business Wire

Is Lucira Health a Good Stock to Buy Right Now?

This start-up's over-the-counter COVID-19 tests could be a huge hit.

4 months ago - The Motley Fool

Lucira Health Announces First Quarter 2021 Financial Results

EMERYVILLE, Calif, May 13, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health," "Lucira" or the "Company") (NASDAQ: LHDX), a medical technology company focused on the development and commercia...

5 months ago - GlobeNewsWire

Why Second Sight Medical, Lucira Health, RA Medical Are Moving Today

Second Sight Medical Products, Inc. (NASDAQ: EYES), Lucira Health, Inc. (NASDAQ: LHDX) and Ra Medical Systems, Inc. (NYSE: RMED) were among the biggest health care gainers Wednesday. Second Sight Rallie...

Other symbols:EYESRMED
5 months ago - Benzinga

Lucira Health to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference

EMERYVILLE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of tr...

5 months ago - GlobeNewsWire

Is Lucira Health a Buy?

This coronavirus testing stock has taken shareholders on a roller-coaster ride since its IPO.

5 months ago - The Motley Fool

Lucira Health to Announce First Quarter 2021 Financial Results

EMERYVILLE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of ...

5 months ago - GlobeNewsWire

Lucira Health Celebrates Grand Opening of New Jabil Manufacturing Plant, Increasing Production of LUCIRA CHECK IT™ CO...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

Other symbols:JBL
5 months ago - Business Wire

Health Canada Authorizes First COVID-19 Test For Self-Testing At Home

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

5 months ago - Business Wire

For the First Time Ever, NBA Fans Can Test Themselves for COVID-19 Before Attending a Live Game. Testing Program Debu...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

6 months ago - Business Wire

Why Lucira Health Stock Is Plunging Today

This analyst thinks the company's stock performance will trail that of the market.

6 months ago - The Motley Fool

Why Lucira Health Stock Skyrocketed Today

The company's COVID-19 Test Kit will soon be available for sale at a pharmacy near you.

6 months ago - The Motley Fool

FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT™ COVID-19 At-Home Test. Available...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

6 months ago - Business Wire